Overview
- 14 public-safe observations are available for this inspection.
- 7 structured CFR citations are represented.
- 3 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
20 Nov 2017
21 CFR 211.80(a)
Procedures To Be in Writing
Cited by Jose O Hernandez, Ronald Ifraimov, Marion Michaelis
20 Nov 2017
21 CFR 211.80(a)
Procedures To Be in Writing
Cited by Jose O Hernandez, Ronald Ifraimov, Marion Michaelis
20 Nov 2017
21 CFR 803.17
Lack of Written MDR Procedures
Cited by Jose O Hernandez, Ronald Ifraimov, Marion Michaelis
20 Nov 2017
21 CFR 803.17
Lack of Written MDR Procedures
Cited by Jose O Hernandez, Ronald Ifraimov, Marion Michaelis
20 Nov 2017
21 CFR 820.100(b)
Documentation
Cited by Jose O Hernandez, Ronald Ifraimov, Marion Michaelis
Inspected site
SCShalon Chemical Industries Ltd.Kiryat Gat, Israel
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 803.17 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.100(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.30(g) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.70(g)(1) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.75(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 820.80(c) | Cited across public-safe Form 483 observations | 2x |
Full 483 report
Get the verbatim text of all 14 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere